vir

Vir Biotechnology, Inc. Rings the Opening Bell in Celebration of its IPO

Date & Time
Location

ABOUT THIS EVENT

Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, visited the Nasdaq Entrepreneurial Center in San Francisco.

In honor of the occasion, George Scangos, CEO, rang the Opening Bell.

 

Nasdaq watch

See what's playing at Nasdaq

WATCH NOW ->